To sign up to the Graham Hancock newsletter mailing list, please click here.
A new line of genetically modified pigs will host transplanted cells without the risk of rejection, opening the door for future stem cell therapy research. One of the biggest challenges for medical researchers studying the effectiveness of stem cell therapies is that transplants or grafts of cells are often rejected by the hosts.
Back to Previous...
Go to News Desk...
Enjoy the newsdesk? Please tell others about it:Tweet
Dedicated Servers and Cloud Servers by Gigenet. Invert Colour Scheme / Default